A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2001
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001055115A8 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001034095A8 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001028583A3 Melanoma vaccine and methods of making and using same
11/29/2001	WO2001017550A3 Vaccine against hbv and hpv
11/29/2001	WO2000073469A3 Protein kinases
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010047030 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046988 Especially treating fibromyalgia, chronic fatigue syndrome, psychogenic pain and chromic pain
11/29/2001	US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain
11/29/2001	US20010046490 Cell surface molecule-induced macrophage activation
11/29/2001	US20010046489 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
11/29/2001	US20010046483 Medicaments for manipulating T-cell immune response
11/29/2001	DE10025045A1 Mittel zur Stimulation des Immunsystems Means for stimulation of the immune system
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410642A1 Modulation of t-cell receptor interactions
11/29/2001	CA2410563A1 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2410083A1 Mammalian receptor proteins; related reagents and methods
11/29/2001	CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits
11/29/2001	CA2408749A1 Drug screening systems and assays
11/29/2001	CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408145A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2408125A1 Synthetic peptides and uses therefore
11/29/2001	CA2407964A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407767A1 Compositions containing a benzamide disulfide derivative for treating allergic diseases
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2405459A1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157701A1 Method for obtaining olive leaf extracts and applications thereof
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP1157123A1 Stable recombinant influenza viruses free of helper viruses
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157101A1 Drug design based on the structure of lta 4? hydrolase
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157042A1 Production of tetravalent antibodies
11/28/2001	EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1156826A1 Product and method for treatment of conditions associated with receptor-desensitization
11/28/2001	EP1156825A2 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
11/28/2001	EP1156824A2 Compositions and methods for treating cancer and hyperproliferative disorders
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156814A2 Novel pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP1156717A1 A recombinant polypeptide for use in the manufacture of vaccines against campylobacter induced diarrhea and to reduce colonization
11/28/2001	EP1054685B1 Liquid crystal forms of cyclosporin
11/28/2001	EP0914129B1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/28/2001	EP0880350B1 Multiple sclerosis treatment
11/28/2001	EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0770068B1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001	CN1324363A Calcium (3S) tetrahydro-3-furanyl (1S, 2R)-3-[[(4-aminophenyl)sulfonyl] (isobutyl) amino]-1-benzyl-2-(phosphonooxy) propylcarbamate
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324354A Vitreous form of know bradykinin antagonist
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001	CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001	CN1323889A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
11/28/2001	CN1323827A New polypeptide-human transcriptional activation protein subunit 14 and polynucleotides for coding same
11/28/2001	CN1323816A New polypeptide-human L1 reverse transcription factor 22 and polynucleotides for coding same
11/28/2001	CN1323793A Schizonepeta lactone and its extraction process and use
11/28/2001	CN1323624A Xueduqing capsule, oral liquid and mask for eliminating blood toxin
11/28/2001	CN1323623A Multipurpose medicine made of bamboo liquid and honey and its prepn.
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323210 Transferase inhibitor
11/27/2001	US6323206 Antiinflammatory agents and viricides for aids with cytokinesand chemokines
11/27/2001	US6323200 The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the t-helper-type 2 immune response.
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6322982 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
11/27/2001	US6322796 Immunological tolerance-inducing agent

1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1172